Inogen gives Rove 6 green light in US
By HME News Staff
Updated 9:38 AM CDT, Tue August 8, 2023
GOLETA, Calif. – Inogen has launched the Rove 6 portable oxygen concentrator in the United States with an eight-year expected service life. The company launched the Rove 6 in Europe in December. Inogen has also extended the eight-year expected service life to its Inogen One G5 POC in the United States. “In capital-based business models it is critical to maximize the value of the devices you invest in to enhance your returns,” said Nabil Shabshab, president and CEO. “We are excited to now be able to extend this opportunity to Inogen’s business-to-business customers allowing them to improve the profitability of their oxygen concentrator business and strengthen the appeal of the non-delivery long-term oxygen therapy model. As a global market leader with a focus on delivering high quality and innovative respiratory care solutions, Inogen is well positioned to deliver the best portable oxygen concentrator for business-to-business customers, with a differentiated value proposition through a strong total cost of ownership, best-in-class quality, best after sales services, and now the best-in-class expected service life.” The Rove 6 is a six-setting POC with a long battery life. It delivers up to 1,260 mL/minute of medical grade oxygen at a weight of only 4.8 pounds. It’s available with two battery options, including an extended battery that can support up to 12 hours and 45 minutes of use.
Comments